Managers

German diagnostics firm Spingotec lands funding

Germany-based Sphingotec, a diagnostics company, has secured 20 million euros in financing. HBM and Wellington Partners led the round.

VC-backed Atlas Genetics rebrands as Binx Health

UK-based Atlas Genetics, a near patient and point-of-care testing company, has rebranded as Binx Health. Also, Binx Health has appointed Dr. Howard Heller as chief medical officer. Binx Health's backers include Johnson & Johnson Innovation, Novartis Venture Fund, LSP Venture Capital, BB Biotech, RMI Investments and Technology Ventures Partners.

Mosaic Ventures amasses $150 mln for sophomore fund

Mosaic Ventures has raised $150 million for its second fund. The London-based early-stage venture firm is focused on Series A investments.

Sequoia stands atop most active VC list for Q3

Kraft Heinz launches $100 mln venture fund

Kraft Heinz has launched Evolv Ventures, a Chicago-based venture fund focused on food tech companies. Kraft Heinz has committed up to $100 million to Evolv and has named Bill Pescatello, a former partner at Lightbank, to lead the fund.

5AM Ventures targets $350 mln for fourth fund

5AM Ventures is seeking to raise $350 million for its fourth fund, according to an SEC filing. Based in San Francisco and Boston, the venture firm invests in early-stage life science companies.

Humbition collects $30 mln for new fund

Humbition, a newly launched early-stage venture firm focused on founder-led companies in New York City, has raised $30 million for its new fund. Zocdoc founder Cyrus Massoumi and Indiegogo founder Slava Rubin lead Humbition.

AI takes over the busywork in sales, freeing sales staff to do what they do best

CSA Medical snags $15 mln venture loan facility from Horizon

Horizon Technology Finance Corp has provided a $15 million venture loan facility to CSA Medical Inc. Based in Lexington, Massachusetts, CSA Medical is a producer of cryotherapy medical devices.

Epiris wraps up new fund

UK-based private equity firm Epiris has closed its new fund at 821 million pounds. The fund's investors include public and private pension funds, endowments and foundations, asset managers and private investors. Campbell Lutyens was the financial adviser and placement agent.